TRIP6 (thyroid hormone receptor interactor 6) is a versatile adaptor protein that functions as a cytoplasmic signaling hub and nuclear transcriptional coregulator. The protein contains three LIM domains that facilitate protein-protein interactions and enable its diverse cellular functions 1. TRIP6 primarily localizes to focal adhesions and cytosol, where it coordinates cell motility through actin cytoskeleton reorganization and promotes cell invasiveness by weakening adherens junctions 2. Mechanistically, TRIP6 interacts with PDZ domain-containing proteins like PARD3 to disrupt tight junctions, inhibits PTEN, and activates oncogenic Akt signaling pathways 3. The protein can shuttle to the nucleus where it serves as a transcriptional coactivator for NF-κB and JUN pathways 2. TRIP6 also associates with telomeres in a subset of human cells, potentially contributing to genome stability and telomere protection 4. In disease contexts, TRIP6 is significantly upregulated in colorectal cancer, particularly in liver metastases, and high expression correlates with poor patient prognosis 35. The protein promotes epithelial-mesenchymal transition, cell migration, invasion, and metastasis, making it an attractive therapeutic target for cancer treatment 35.